A new experimental drug lowered blood pressure and sharply reduced signs of kidney damage in people with chronic kidney disease. Baxdrostat, an investigational pill designed to block production of the hormone aldosterone, showed encouraging results in people facing a difficult and dangerous combination: chronic kidney disease and uncontrolled high blood pressure. In a Phase 2 […]